The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
Open accessAbstract
BET bromodomain inhibition treats heart failure by blocking innate inflammatory and profibrotic gene networks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“BET inhibition exerted a strong protective effect on left ventricular ejection fraction (Fig. 1B)4,6-10.”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“As BET proteins are transcriptional co-activators and their inhibition is associated with protection in heart failure models6-8”
From Chromatin remodelling drives immune cell–fibroblast communication in heart failure (2024) · cites this paper as [8]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Differential expression analysis for sequence count data
Anders, S., & Huber, W. (2010) · Genome Biology · doi:10.1186/gb-2010-11-10-r106 · Cited by 15,581
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Causal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
Self-citationSuper-enhancers in the control of cell identity and disease
Hnisz, D., Abraham, B. J., Lee, T. I., Lau, A., Saint-André, V., Sigova, A. A., Hoke, H. A., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.09.053 · Cited by 3,662 · cited 1×
“Target gene specificity is achieved, in part, because the BRD4 coactivator protein is asymmetrically enriched at massive cell state–specific enhancers (or superenhancers) (26, 27).”
BackgroundSelective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Lovén, J., Hoke, H. A., Lin, C. Y., Lau, A., Orlando, D. A., Vakoc, C. R., Bradner, J. E., Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.03.036 · Cited by 2,961
Self-citationBET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,888
Self-citationRNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Self-citationPhthalimide conjugation as a strategy for in vivo target protein degradation
Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760
Self-citationTranscriptional Regulation and Its Misregulation in Disease
Lee, T. I., & Young, R. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.014 · Cited by 1,676
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
Writing Group Members, Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182456d46 · Cited by 1,512
Jang, M. K., Mochizuki, K., Zhou, M., Jeong, H., Brady, J. N., & Ozato, K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.027 · Cited by 1,301
Recruitment of P-TEFb for Stimulation of Transcriptional Elongation by the Bromodomain Protein Brd4
Yang, Z., Yik, J. H. N., Chen, R., He, N., Jang, M. K., Ozato, K., & Zhou, Q. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.029 · Cited by 1,141
Hill, J. A., & Olson, E. N. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072139 · Cited by 1,111
Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
Pfeffer, M. A., Lamas, G. A., Vaughan, D. E., Parisi, A. F., & D, E. B. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807143190204 · Cited by 1,101
Gao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney & Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M. P., Chen, W., & Frangogiannis, N. G. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 958
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J. M., Maliken, B. D., Correll, R. N., Brody, M. J., Lin, S. J., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 926
The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
Shi, J., & Vakoc, C. R. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.05.016 · Cited by 888
Sutton, M. S. J., Pfeffer, M. A., Plappert, T. A., Rouleau, J. L., Moyé, L. A., Dagenais, G. R., Lamas, G. A., Klein, M., Sussex, B. A., & Goldman, S. (1994) · Circulation · doi:10.1161/01.cir.89.1.68 · Cited by 821
Left Ventricular Remodeling in Heart Failure
Konstam, M. A., Kramer, D. G., Patel, A. R., Maron, M. S., & Udelson, J. E. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2010.10.008 · Cited by 808
Chapuy, B., McKeown, M. R., Lin, C. Y., Monti, S., Roemer, M. G. M., Qi, J., Rahl, P. B., Sun, H. H., Yeda, K. T., Doench, J. G., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.003 · Cited by 735
Self-citationInnate Immunity and the Failing Heart
Mann, D. L. (2015) · Circulation Research · doi:10.1161/circresaha.116.302317 · Cited by 690
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shu, S., Lin, C. Y., He, H. H., Witwicki, R. M., Tabassum, D. P., Roberts, J. M., Janiszewska, M., Jin Huh, S., Liang, Y., Ryan, J., et al. (2016) · Nature · doi:10.1038/nature16508 · Cited by 632
Self-citationNF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
Brown, J. D., Lin, C. Y., Duan, Q., Griffin, G., Federation, A. J., Paranal, R. M., Bair, S., Newton, G., Lichtman, A. H., Kung, A. L., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.08.024 · Cited by 614
Self-citationMolecular basis of physiological heart growth: fundamental concepts and new players
Maillet, M., van Berlo, J. H., & Molkentin, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3495 · Cited by 536
Signaling effectors underlying pathologic growth and remodeling of the heart
van Berlo, J. H., Maillet, M., & Molkentin, J. D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62839 · Cited by 460
Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study
Berthon, C., Raffoux, E., Thomas, X., Vey, N., Gomez‐Roca, C., Yee, K. W. L., Taussig, D. C., Rezaï, K., Roumier, C., Herait, P., et al. (2016) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00247-1 · Cited by 432
Small-Molecule Inhibition of BRDT for Male Contraception
Matzuk, M. M., McKeown, M. R., Filippakopoulos, P., Li, Q., Ma, L., Agno, J. E., Lemieux, M. E., Picaud, S., Yu, R. N., Qi, J., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.045 · Cited by 430
Self-citationC/EBPβ Controls Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling
Boström, P., Mann, N., Wu, J., Quintero, P. A., Plovie, E. R., Panáková, D., Gupta, R. K., Xiao, C., MacRae, C. A., Rosenzweig, A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.036 · Cited by 411
BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
Anand, P., Brown, J. D., Lin, C. Y., Qi, J., Zhang, R., Artero, P. C., Alaiti, M. A., Bullard, J., Alazem, K., Margulies, K. B., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.013 · Cited by 406 · cited 10×
“Furthermore, JQ1 does not cause major changes in cardiac structure or function inmice subject to sham surgery (31).”
BackgroundMethodResultInfluentialSelf-citationTargeting Epigenetic Readers in Cancer
Dawson, M. A., Kouzarides, T., & Huntly, B. J. P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112635 · Cited by 405
Liu, X., Xiao, J., Zhu, H., Wei, X., Platt, C., Damilano, F., Xiao, C., Bezzerides, V. J., Boström, P., Che, L., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.014 · Cited by 397
Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription
Bisgrove, D. A., Mahmoudi, T., Henklein, P., & Verdin, E. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705053104 · Cited by 386
Koitabashi, N., Danner, T., Zaiman, A., Pinto, Y. M., Rowell, J., Mankowski, J. L., Zhang, D., Nakamura, T., Takimoto, E., & Kass, D. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44824 · Cited by 335
Toward transcriptional therapies for the failing heart: chemical screens to modulate genes
McKinsey, T. A., & Olson, E. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24144 · Cited by 288
Self-citationTranscriptional Genomics Associates FOX Transcription Factors With Human Heart Failure
Hannenhalli, S. S., Putt, M., Gilmore, J. M., Wang, J., Parmacek, M. S., Epstein, J. A., Morrisey, E. E., Margulies, K. B., & Cappola, T. P. (2006) · Circulation · doi:10.1161/circulationaha.106.632430 · Cited by 257
Sano, M., Abdellatif, M., Oh, H., Xie, M., Bagella, L., Giordano, A., Michael, L. H., DeMayo, F. J., & Schneider, M. D. (2002) · Nature Medicine · doi:10.1038/nm778 · Cited by 236
BRD4 is a novel therapeutic target for liver fibrosis
Ding, N., Hah, N., Yu, R. T., Sherman, M. H., Benner, C., Leblanc, M., He, M., Liddle, C., Downes, M., & Evans, R. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522163112 · Cited by 211
Bolden, J. E., Tasdemir, N., Dow, L. E., van Es, J. H., Wilkinson, J. E., Zhao, Z., Clevers, H. C., & Lowe, S. W. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.025 · Cited by 194
Myocardial Infarction and Cardiac Remodelling in Mice
Yang, F., Liu, Y., Yang, X., Xu, J., Kapke, A., & Carretero, O. A. (2002) · Experimental Physiology · doi:10.1113/eph8702385 · Cited by 191
BET acetyl-lysine binding proteins control pathological cardiac hypertrophy
Spiltoir, J. I., Stratton, M. S., Cavasin, M. A., Demos-Davies, K., Reid, B. G., Qi, J., Bradner, J. E., & McKinsey, T. A. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.07.017 · Cited by 174
Self-citationZhou, H., Dickson, M. E., Kim, M. S., Bassel‐Duby, R., & Olson, E. N. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516237112 · Cited by 172
BET Bromodomain Inhibition Releases the Mediator Complex from Select cis-Regulatory Elements
Bhagwat, A. S., Roe, J., Mok, B. Y., Hohmann, A. F., Shi, J., & Vakoc, C. R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.03.054 · Cited by 169
Transcriptional Landscape of Cardiomyocyte Maturation
Uosaki, H., Cahan, P., Lee, D. I., Wang, S., Miyamoto, M., Fernandez, L., Kass, D. A., & Kwon, C. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.032 · Cited by 163
NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler
Shen, C., Ipsaro, J. J., Shi, J., Milazzo, J. P., Wang, E., Roe, J., Suzuki, Y., Pappin, D., Joshua‐Tor, L., & Vakoc, C. R. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.033 · Cited by 158
Matkovich, S. J., Edwards, J. R., Grossenheider, T. C., Strong, C. D. G., & Dorn, G. W. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410622111 · Cited by 142
Bellinger, A. M., Arteaga, C. L., Force, T. L., Humphreys, B. D., Demetri, G. D., Druker, B. J., & Moslehi, J. J. (2015) · Circulation · doi:10.1161/circulationaha.115.010484 · Cited by 119
Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation
Haldar, S. M., Lu, Y., Jeyaraj, D., Kawanami, D., Cui, Y., Eapen, S. J., Hao, C., Li, Y., Doughman, Y., Watanabe, M., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000502 · Cited by 111
Self-citationJm, P., Ma, P., & D, E. B. M. (1987) · PubMed · Cited by 109
Carlson, C. B., Koonce, C. H., Aoyama, N., Einhorn, S., Fiene, S., Thompson, A., Swanson, B., Anson, B. D., & Kattman, S. J. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113500812 · Cited by 100
Song, H. K., Hong, S., Kim, T.-Y., & Kim, D. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035552 · Cited by 95
Signal-Dependent Recruitment of BRD4 to Cardiomyocyte Super-Enhancers Is Suppressed by a MicroRNA
Stratton, M. S., Lin, C. Y., Anand, P., Tatman, P. D., Ferguson, B. S., Wickers, S. T., Ambardekar, A. V., Sucharov, C. C., Bradner, J. E., Haldar, S. M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.074 · Cited by 86
Self-citationResearch Advances in Heart Failure
Braunwald, E. (2013) · Circulation Research · doi:10.1161/circresaha.113.302254 · Cited by 72
SUN, Y., Huang, J., & Song, K. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2789 · Cited by 64
Unsöld, B. W., Kaul, A., Sbroggió, M., Schubert, C., Regitz‐Zagrosek, V., Brancaccio, M., Damilano, F., Hirsch, E., van Bilsen, M., Munts, C., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt235 · Cited by 52
BET-ting on chromatin-based therapeutics for heart failure
Haldar, S. M., & McKinsey, T. A. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.002 · Cited by 51
Self-citationLee, D. U., Katavolos, P., Palanisamy, G. S., Katewa, A., Sioson, C., Corpuz, J., Pang, J., DeMent, K., Choo, E. F., Ghilardi, N., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.03.013 · Cited by 47
Genetics and Disease of Ventricular MusclePreprint
Fatkin, D., Seidman, C. E., & Seidman, J. G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021063 · Cited by 45
Xu, L., Yates, C., Lockyer, P., Xie, L., Bevilacqua, A., He, J., Lander, C., Patterson, C., & Willis, M. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.09.011 · Cited by 41
Epigenetic Mechanisms in Heart Failure Pathogenesis
Salvo, T. G. D., & Haldar, S. M. (2014) · Circulation Heart Failure · doi:10.1161/circheartfailure.114.001193 · Cited by 38
Self-citationvon Schaper, E. (2016) · Nature Biotechnology · doi:10.1038/nbt0416-361 · Cited by 12
Leinonen, J., Emanuelov, A. K., Wolf, Y., Milgrom-Hoffman, M., Lichtstein, D., Hoss, S., Lotan, C., Tzahor, E., Jung, S., & Beeri, R. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.040 · Cited by 11
Flagged first, then by citations
Research works printed but not linked: 1
- National Research Council Guide for the Care and Use of Laboratory Animals (National Acadmies Press 8th ed. 2011).
Cited by
Sorted by citations
Role of the gut microbiota in nutrition and health
Valdes, A. M., Walter, J., Segal, E., & Spector, T. D. (2018) · BMJ · doi:10.1136/bmj.k2179 · Cited by 2,375
Microglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935
Frangogiannis, N. G. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvaa324 · Cited by 1,229
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Gilan, O., Rioja, I., Knezevic, K., Bell, M. J., Yeung, M. M., Harker, N., Lam, E. Y. N., Chung, C., Bamborough, P., Petretich, M., et al. (2020) · Science · doi:10.1126/science.aaz8455 · Cited by 453
Bromodomains: a new target class for drug development
Cochran, A. G., Conery, A. R., & Sims, R. J. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0030-7 · Cited by 450
Metadata
- Authors
- Duan, Q., McMahon, S., Anand, P., Shah, H., Thomas, S., Salunga, H. T., Huang, Y., Zhang, R., Sahadevan, A., Lemieux, M. E., Brown, J. D., Srivastava, D., Bradner, J. E., McKinsey, T. A., & Haldar, S. M.
- Affiliations
- Gladstone Institutes (US)
- University Hospitals of Cleveland (US)
- 1QBit (CA)
- Vanderbilt University (US)
- Harvard University (US)
- University of Colorado Anschutz (US)
- Corresponding author
- Duan, Qiming
- McMahon, Sarah
- Haldar, Saptarsi M.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2017-05-17
- Volume
- 9
- Issue
- 390
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC5544253
- OpenAlex
- W2616008841
- Cited by
- 262
- References
- 70
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 20 · 2023: 28 · 2022: 32 · 2021: 36 · 2020: 36 · 2019: 33 · 2018: 23 · 2017: 8
- FWCI
- 11.16
- Type
- journal article
- Language
- en
- Update notices
- correction (2025-02-19)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (award298115, HL116848, award298112, HL127240)
- National Institute of Diabetes and Digestive and Kidney Diseases (award298116, DK093821)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- heart failure, BET bromodomain inhibition, BRD4, JQ1, epigenetic therapy, cardiac hypertrophy, NF-κB signaling, TGF-beta signaling, myocarditis, myocardial fibrosis, pressure overload, myocardial infarction, iPSC-derived cardiomyocytes, chromatin regulation, gene regulatory networks
- MeSH terms
- Bromodomain Containing Proteins, Animals, Azepines, Cardiomegaly, Heart Failure, Humans, Inflammation, Male, Mice, Inbred C57BL, Proteins, Triazoles, Signal Transduction, Transforming Growth Factor beta, NF-kappa B, Myocytes, Cardiac, Mice, Gene Regulatory Networks, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
